Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2017
In Reply to Hamstra et al
W James Morris
Brachytherapy
|
December 24, 2013
Rebuttal to Drs Stone and Stock
Ingrid Spadinger, W James Morris
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2017
In Regard to Ciezki et al
W James Morris, Scott Tyldesley
Brachytherapy
|
August 27, 2010
Point: the relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: is there an elephant in the room?
W James Morris, Ross Halperin, Ingrid Spadinger
Brachytherapy
|
September 25, 2018
Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial
W James Morris, Tom Pickles, Mira Keyes
Brachytherapy
|
October 17, 2017
High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy
Tom Pickles, W James Morris, Mira Keyes
International Journal of Radiation Oncology, Biology, Physics
|
July 3, 2009
Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis
Tom Pickles, Mira Keyes, W James Morris
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2017
ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
Sree Rodda, W James Morris, Jeremy Hamm, et al.
Brachytherapy
|
November 25, 2010
Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants
Nawaid Usmani, Nick Chng, Ingrid Spadinger, et al.
Brachytherapy
|
June 29, 2012
Toxicity after (125)I prostate brachytherapy in patients with inflammatory bowel disease
Howard H Pai, Mira Keyes, W James Morris, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2017
In Reply to Hamstra et al
W James Morris
Brachytherapy
|
December 24, 2013
Rebuttal to Drs Stone and Stock
Ingrid Spadinger, W James Morris
International Journal of Radiation Oncology, Biology, Physics
|
August 18, 2017
In Regard to Ciezki et al
W James Morris, Scott Tyldesley
Brachytherapy
|
August 27, 2010
Point: the relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: is there an elephant in the room?
W James Morris, Ross Halperin, Ingrid Spadinger
Brachytherapy
|
September 25, 2018
Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial
W James Morris, Tom Pickles, Mira Keyes
Brachytherapy
|
October 17, 2017
High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy
Tom Pickles, W James Morris, Mira Keyes
International Journal of Radiation Oncology, Biology, Physics
|
July 3, 2009
Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis
Tom Pickles, Mira Keyes, W James Morris
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2017
ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
Sree Rodda, W James Morris, Jeremy Hamm, et al.
Brachytherapy
|
November 25, 2010
Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants
Nawaid Usmani, Nick Chng, Ingrid Spadinger, et al.
Brachytherapy
|
June 29, 2012
Toxicity after (125)I prostate brachytherapy in patients with inflammatory bowel disease
Howard H Pai, Mira Keyes, W James Morris, et al.
Page
of 7